On this basis, candidate biomarkers must undergo rigorous mechanism validation and clinical association testing to ensure that they accurately reflect the pathological and physiological status of specific tissues, such as the level of quinoline acid(QA) in neuroinflammation or IDO1 activity in the tumor microenvironment (Wang et al., 2024). Here, IDO1 is linked to neoplasm.